222 related articles for article (PubMed ID: 28358373)
1. Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres.
Salsman J; Rapkin LM; Margam NN; Duncan R; Bazett-Jones DP; Dellaire G
Cell Death Dis; 2017 Mar; 8(3):e2724. PubMed ID: 28358373
[TBL] [Abstract][Full Text] [Related]
2. PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX.
Delbarre E; Ivanauskiene K; Spirkoski J; Shah A; Vekterud K; Moskaug JØ; Bøe SO; Wong LH; Küntziger T; Collas P
Genome Res; 2017 Jun; 27(6):913-921. PubMed ID: 28341773
[TBL] [Abstract][Full Text] [Related]
3. DAXX silencing suppresses mouse ovarian surface epithelial cell growth by inducing senescence and DNA damage.
Pan WW; Yi FP; Cao LX; Liu XM; Shen ZF; Bu YQ; Xu Y; Fan HY; Song FZ
Gene; 2013 Sep; 526(2):287-94. PubMed ID: 23542781
[TBL] [Abstract][Full Text] [Related]
4. PML is recruited to heterochromatin during S phase and represses DAXX-mediated histone H3.3 chromatin assembly.
Shastrula PK; Sierra I; Deng Z; Keeney F; Hayden JE; Lieberman PM; Janicki SM
J Cell Sci; 2019 Mar; 132(6):. PubMed ID: 30796101
[TBL] [Abstract][Full Text] [Related]
5. Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX.
Ishov AM; Vladimirova OV; Maul GG
J Cell Sci; 2004 Aug; 117(Pt 17):3807-20. PubMed ID: 15252119
[TBL] [Abstract][Full Text] [Related]
6. Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis.
Cohen C; Corpet A; Roubille S; Maroui MA; Poccardi N; Rousseau A; Kleijwegt C; Binda O; Texier P; Sawtell N; Labetoulle M; Lomonte P
PLoS Pathog; 2018 Sep; 14(9):e1007313. PubMed ID: 30235352
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization.
Corpet A; Olbrich T; Gwerder M; Fink D; Stucki M
Cell Cycle; 2014; 13(2):249-67. PubMed ID: 24200965
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
Lehembre F; Müller S; Pandolfi PP; Dejean A
Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
[TBL] [Abstract][Full Text] [Related]
9. Role of SUMO-1-modified PML in nuclear body formation.
Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
[TBL] [Abstract][Full Text] [Related]
10. Solubility changes of promyelocytic leukemia (PML) and SUMO monomers and dynamics of PML nuclear body proteins in arsenite-treated cells.
Hirano S; Udagawa O; Kobayashi Y; Kato A
Toxicol Appl Pharmacol; 2018 Dec; 360():150-159. PubMed ID: 30292834
[TBL] [Abstract][Full Text] [Related]
11. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation.
Muromoto R; Ishida M; Sugiyama K; Sekine Y; Oritani K; Shimoda K; Matsuda T
J Immunol; 2006 Jul; 177(2):1160-70. PubMed ID: 16818774
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ChRO1 facilitates ATRX/DAXX-dependent H3.3 deposition for transcription-associated heterochromatin reorganization.
Park J; Lee H; Han N; Kwak S; Lee HT; Kim JH; Kang K; Youn BH; Yang JH; Jeong HJ; Kang JS; Kim SY; Han JW; Youn HD; Cho EJ
Nucleic Acids Res; 2018 Dec; 46(22):11759-11775. PubMed ID: 30335163
[TBL] [Abstract][Full Text] [Related]
13. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
[TBL] [Abstract][Full Text] [Related]
14. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
15. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG
J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530
[TBL] [Abstract][Full Text] [Related]
16. Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.
Zhong S; Salomoni P; Ronchetti S; Guo A; Ruggero D; Pandolfi PP
J Exp Med; 2000 Feb; 191(4):631-40. PubMed ID: 10684855
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic Leukemia Protein Potently Restricts Human Cytomegalovirus Infection in Endothelial Cells.
Seitz S; Heusel AT; Stamminger T; Scherer M
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233232
[TBL] [Abstract][Full Text] [Related]
18. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein.
Tang J; Wu S; Liu H; Stratt R; Barak OG; Shiekhattar R; Picketts DJ; Yang X
J Biol Chem; 2004 May; 279(19):20369-77. PubMed ID: 14990586
[TBL] [Abstract][Full Text] [Related]
19. PML Alternative Splice Products Differentially Regulate HAdV Productive Infection.
Mai J; Stubbe M; Hofmann S; Masser S; Dobner T; Boutell C; Groitl P; Schreiner S
Microbiol Spectr; 2022 Aug; 10(4):e0078522. PubMed ID: 35699431
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
